Tenpoint Therapeutics
Develops treatments to rejuvenate vision in the aging eye
$235MSeries B
Role not disclosedActivity from announced rounds
Develops treatments to rejuvenate vision in the aging eye
Pitching Eight Roads? Send the deck from a free RoundOS data room and see which pages they read.